The decision of the General Court of the European Union in the Pfizergate case would allow the European Commission to ...

Industry sources reveal drug companies have stopped negotiating listings on the PBS and in some cases are considering not ...

Pfizer's CEO discussed the extensive due diligence the company has conducted on the 3SBio PD-1xVEGF deal. | Pfizer's CEO ...

President Isaac Herzog and Genesis Prize Foundation chairman Stan Polovets presented the award, praising Milei as a “moral ...

Deep Apple Therapeutics Inc. could bring in as much as $812 million in a new collaboration and license deal with Novo Nordisk A/S. The total includes an unspecified up-front payment, research costs ...

Pfizer Inc. (NYSE:PFE) is one of the best wide moat stocks to buy now. On June 9, Pfizer, along with other drug manufacturers ...

Americas Society recognized Venezuela's opposition leader and two business executives with the Gold Medal for their impact on ...

Pfizer’s CEO Albert Bourla disclosed that the company recently met with the Trump administration to discuss lowering U.S.

Sbio Inc. reported interim phase II study results of its PD-1/VEGF bispecific antibody, SSGJ-707 – a “fabulous” asset, according to Pfizer Inc. CEO Albert Bourla, that landed in Pfizer’s cancer ...

BioSpace did a deep dive into executive pay, examining the highest compensation packages, pay ratios and golden ...

While pharmaceutical executives raise valid concerns about the lack of detailed implementation plans for the “Most Favored ...

According to the order, the administration was to set "most favored nation" price targets within 30 days. The Department of ...